Literature DB >> 16940238

Relationship between oxidative stress and antioxidant systems in the liver of patients with Wilson disease: hepatic manifestation in Wilson disease as a consequence of augmented oxidative stress.

Hironori Nagasaka1, Ikuo Inoue, Ayano Inui, Haruki Komatsu, Tsuyoshi Sogo, Kei Murayama, Tomoko Murakami, Tohru Yorifuji, Kotaro Asayama, Shigeo Katayama, Shinji Uemoto, Kunihiko Kobayashi, Masaki Takayanagi, Tomoo Fujisawa, Hirokazu Tsukahara.   

Abstract

The role of oxidative stress in the pathogenesis of liver disease in Wilson disease (WD), a genetic disorder characterized by excess hepatic deposition of copper that generates free radicals, remains unclear. This study investigates oxidative stress on the liver and hepatic antioxidant responses in WD using liver specimens from affected patients showing mild liver damage (group I, n = 3), moderate or greater liver damage (group II, n = 5), and fulminant hepatic failure (group III, n = 5) and from asymptomatic carriers (n = 2). Decreased ratios of reduced glutathione (GSH) to oxidized glutathione (GSSG) and increased thiobarbituric acid reactive substance (TBARS), a lipid peroxidation product, were found in every affected patient, especially in group II and III patients. Activities and protein expressions of Mn-dependent superoxide dismutase (Mn-SOD), CuZn-dependent superoxide dismutase (CuZn-SOD), and catalase were decreased in all patients, especially in group III patients. Glutathione peroxidase (GPx) activity was decreased only in group III patients. Asymptomatic carriers without any clinical manifestations showed normal TBARS level and GSH/GSSG ratio with increases in both GSH and GSSG levels. Their CuZn-SOD, Mn-SOD, and catalase activities were increased. These results suggest that excessive copper-derived oxidants contribute to development and progression of liver disease in WD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16940238     DOI: 10.1203/01.pdr.0000238341.12229.d3

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  24 in total

1.  Hepatocyte GP73 expression in Wilson disease.

Authors:  Lorinda M Wright; Dominik Huster; Svetlana Lutsenko; Fritz Wrba; Peter Ferenci; Claus J Fimmel
Journal:  J Hepatol       Date:  2009-06-25       Impact factor: 25.083

Review 2.  A review and current perspective on Wilson disease.

Authors:  Mallikarjun Patil; Keyur A Sheth; Adarsh C Krishnamurthy; Harshad Devarbhavi
Journal:  J Clin Exp Hepatol       Date:  2013-07-06

3.  Metabolic dysregulation in the Atp7b -/- Wilson's disease mouse model.

Authors:  Clavia Ruth Wooton-Kee; Matthew Robertson; Ying Zhou; Bingning Dong; Zhen Sun; Kang Ho Kim; Hailan Liu; Yong Xu; Nagireddy Putluri; Pradip Saha; Cristian Coarfa; David D Moore; Alli M Nuotio-Antar
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-10       Impact factor: 11.205

4.  Decreased serum antioxidant capacity in patients with Wilson disease is associated with neurological symptoms.

Authors:  Radan Bruha; Libor Vitek; Zdenek Marecek; Lenka Pospisilova; Sona Nevsimalova; Pavel Martasek; Jaromir Petrtyl; Petr Urbanek; Alena Jiraskova; Ivana Malikova; Martin Haluzik; Peter Ferenci
Journal:  J Inherit Metab Dis       Date:  2011-12-03       Impact factor: 4.982

5.  Movement Disorder in Copper Toxicity Rat Model: Role of Inflammation and Apoptosis in the Corpus Striatum.

Authors:  Jayantee Kalita; Vijay Kumar; Usha K Misra; Himangsu K Bora
Journal:  Neurotox Res       Date:  2019-12-06       Impact factor: 3.911

Review 6.  Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases.

Authors:  Carlotta Giorgi; Saverio Marchi; Ines C M Simoes; Ziyu Ren; Giampaolo Morciano; Mariasole Perrone; Paulina Patalas-Krawczyk; Sabine Borchard; Paulina Jędrak; Karolina Pierzynowska; Jędrzej Szymański; David Q Wang; Piero Portincasa; Grzegorz Węgrzyn; Hans Zischka; Pawel Dobrzyn; Massimo Bonora; Jerzy Duszynski; Alessandro Rimessi; Agnieszka Karkucinska-Wieckowska; Agnieszka Dobrzyn; Gyorgy Szabadkai; Barbara Zavan; Paulo J Oliveira; Vilma A Sardao; Paolo Pinton; Mariusz R Wieckowski
Journal:  Int Rev Cell Mol Biol       Date:  2018-06-22       Impact factor: 6.813

7.  Developmental changes in hepatic antioxidant capacity are age-and sex-dependent.

Authors:  Shogo J Miyagi; Isaac W Brown; Jessica M-L Chock; Abby C Collier
Journal:  J Pharmacol Sci       Date:  2009-12       Impact factor: 3.337

8.  Role of Oxidative Stress in the Worsening of Neurologic Wilson Disease Following Chelating Therapy.

Authors:  Jayantee Kalita; Vijay Kumar; Abhay Ranjan; Usha K Misra
Journal:  Neuromolecular Med       Date:  2015-07-30       Impact factor: 3.843

9.  Astrocytes protect against copper-catalysed loss of extracellular glutathione.

Authors:  Simon A S Pope; Rosemary Milton; Simon J R Heales
Journal:  Neurochem Res       Date:  2008-03-12       Impact factor: 3.996

10.  A Study on Apoptosis and Anti-apoptotic Status in Wilson Disease.

Authors:  J Kalita; V Kumar; U K Misra
Journal:  Mol Neurobiol       Date:  2015-12-08       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.